Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Smoot

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Transfusion|January 11, 2013
The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injuryMartin D Zielinski, Dustin L Smoot, James R Stubbs, et al.
Advances in Therapy|October 14, 2022
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USAMarcus J Healey, Brian Seal, Nicole Princic, et al.
Gastrointestinal Endoscopy|May 31, 2003
Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plicationsArnaldo B Feitoza, Christopher J Gostout, Elizabeth Rajan, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 4, 2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor roleEvodie Koutouan, Alejandro Lillo, Ayano Kabashima, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2Boris R A Blechacz, Rory L Smoot, Steven F Bronk, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 10, 2022
Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesionsMatthew Aizpuru, Patrick Starlinger, David M Nagorney, et al.
Hepatology (Baltimore, Md.)|January 12, 2026
Anatomic subsets of cholangiocarcinoma: More different than alikeYawen Dong, Hannah E Stumpf, Rory L Smoot, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 5, 2021
Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysisMichael R Driedger, Thomas S Yamashita, Patrick Starlinger, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 31, 2012
Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinomaVictor Zaydfudim, Rory L Smoot, Clancy J Clark, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinomaNataliya Razumilava, Steve F Bronk, Rory L Smoot, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Transfusion|January 11, 2013
The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injuryMartin D Zielinski, Dustin L Smoot, James R Stubbs, et al.
Advances in Therapy|October 14, 2022
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USAMarcus J Healey, Brian Seal, Nicole Princic, et al.
Gastrointestinal Endoscopy|May 31, 2003
Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plicationsArnaldo B Feitoza, Christopher J Gostout, Elizabeth Rajan, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 4, 2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor roleEvodie Koutouan, Alejandro Lillo, Ayano Kabashima, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2Boris R A Blechacz, Rory L Smoot, Steven F Bronk, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 10, 2022
Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesionsMatthew Aizpuru, Patrick Starlinger, David M Nagorney, et al.
Hepatology (Baltimore, Md.)|January 12, 2026
Anatomic subsets of cholangiocarcinoma: More different than alikeYawen Dong, Hannah E Stumpf, Rory L Smoot, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 5, 2021
Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysisMichael R Driedger, Thomas S Yamashita, Patrick Starlinger, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 31, 2012
Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinomaVictor Zaydfudim, Rory L Smoot, Clancy J Clark, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinomaNataliya Razumilava, Steve F Bronk, Rory L Smoot, et al.
Pageof 18